Seeking Alpha

Rocket Pharmaceuticals: Promising Gene Therapy Play With Discounted Entry Point

Rocket Pharmaceuticals stock trades at ~$19.5 today - back in December 2021 it had hit highs of >$60. The highs were achieved when Rocket's in vivo gene therapy showed promise treating patients with a ...
Seeking Alpha

Rocket stock rises amid data from multiple gene therapy programs

Rocket Pharmaceuticals (NASDAQ:RCKT) reported data from several gene therapy programs at the 26th Annual Meeting of the American Society of Gene and Cell Therapy in Los Angeles. Pyruvate Kinase ...
Nasdaq

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy Designation for RP-L201 Gene Therapy for Leukocyte Adhesion Deficiency-I

— Enrollment Complete in Phase 1/2 Clinical Trial of RP-L201 for the Treatment of LAD-I — “Receiving RMAT designation and completing Phase 1/2 patient enrollment are important steps in advancing our ...
Yahoo

Patient dies in trial of Rocket gene therapy for heart condition

A patient who received an experimental gene therapy developed by Rocket Pharmaceuticals has died following treatment, the company disclosed Tuesday. According to Rocket, the patient experienced what’s ...
PBS

Rocket the therapy dog

Dennis Erickson shares his therapy dog with residents of an Antigo nursing home. Dennis Erickson has spent his career helping people. Today, he brings joy to residents with Rocket, his adopted Jack ...
Nasdaq

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A501 Gene Therapy for Danon Disease

CRANBURY, N.J.--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a leading late-stage biotechnology company advancing an integrated and sustainable pipeline of genetic therapies for rare ...
FierceBiotech

100% overall survival data for gene therapy fuel Rocket for flight to regulators

One hundred percent overall survival in just seven patients has provided the jet fuel needed by Rocket Pharmaceuticals to head to regulators for a rare childhood immunodeficiency disorder gene therapy ...
Benzinga.com

Rocket Pharma Reports Patient Death In Rare Disease Gene Therapy Trial, FDA Puts Clinical Hold

Rocket Pharmaceuticals Inc (NASDAQ:RCKT) announced an update Tuesday related to RP-A501, its investigational gene therapy for Danon disease, a rare X-linked dominant genetic disorder that manifests ...
The Spokesman-Review

Rocket the K9 rallies honorable mention in a national first responder therapy dog contest

North Idaho therapy dog Rocket just took a ride to national recognition for his service in the Kootenai County Sheriff’s K-9 unit. The Brittany spaniel and his handler, John McSwain, a sheriff’s ...
KREM

Rocket the Therapy Dog helps heal hearts in Northern Idaho ambush aftermath

KOOTENAI COUNTY, Idaho — Meet a unique member of the Kootenai County Sheriff's Office. Rocket the Therapy Dog. The Brittany Spaniel provides comfort for first responders across Northern Idaho like Dan ...
Business Wire

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy Designation for RP-L201 Gene Therapy for Leukocyte Adhesion Deficiency-I

CRANBURY, N.J.--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood ...